Wird geladen...

Stroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects

Pancreatic ductal adenocarcinoma (PDAC) is projected to emerge as the second leading cause of cancer-related death after 2030. Extreme treatment resistance is perhaps the most significant factor that underlies the poor prognosis of PDAC. To date, combination chemotherapy remains the mainstay of trea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World J Gastroenterol
Hauptverfasser: Polani, Faran, Grierson, Patrick M, Lim, Kian-Huat
Format: Artigo
Sprache:Inglês
Veröffentlicht: Baishideng Publishing Group Inc 2021
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8117738/
https://ncbi.nlm.nih.gov/pubmed/34025067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v27.i18.2105
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!